Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fast versus slow cyclosporine dose-reduction in adult acquired pure red cell aplasia
ChiCTR2100043485Phase 4Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Apr 2020
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cyclosporine in acquired pure red cell aplasia (PRCA) (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoints: Recurrence rate and Time to recurrence. Started Apr 2020; status: recruiting.
02
Drugs
cyclosporine
03
Conditions
acquired pure red cell aplasia (PRCA)
Beyond the preview
Go deeper on ChiCTR2100043485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043485.